Amgen Inc (NASDAQ:AMGN) on 10/23/2018 declared a dividend of $ 1.3200 per share payable on December 07, 2018 to shareholders of record as of November 16, 2018.

Amgen Inc (NASDAQ:AMGN) has paid dividends since 1997, has a current dividend yield of 2.67% and has increased its dividends for 6 successive years.

Amgen Inc's market cap is $ 128,172,801,440 and has a PE ratio of 53.23. The stock price closed yesterday at $ 198.02 and has a 52 week low/high of $ 163.31 and $ 210.19.

Amgen is a global biotechnology company that discovers, develops, manufactures and delivers human therapeutics. Co. focuses its research and development on human therapeutics for the treatment of illness in the areas of oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology and neuroscience. Co.'s principal products include ENBREL, Neulasta®, Aranesp®, Prolia®, Sensipar®/Mimpara®, XGEVA®, EPOGEN®, and NEUPOGEN®. In addition, Co. markets several other products, including KYPROLIS® (carfilzomib), Vectibix® (panitumumab), Nplate® (romiplostim), Repatha® (evolocumab), BLINCYTO® (blinatumomab), IMLYGIC® (talimogene laherparepvec) and Corlanor® (ivabradine).

For more information on Amgen Inc click here.